We are live on ! Find out more
EWM

Essex Woodlands Management Portfolio holdings

AUM $254M
1-Year Est. Return 4.59%
This Fund
S&P 500
This Quarter Est. Return
-18.93%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$347M
AUM Growth
-$86.5M
Cap. Flow
-$1.39M
Cap. Flow %
-0.4%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
VERO
Venus Concept
VERO
+$14

Top Sells

Rank Stock Value
1
RVNC
Revance Therapeutics, Inc.
RVNC
+$1.39M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDXG icon
1
MiMedx Group
MDXG
$624M
$214M 61.81%
28,195,249
– –
BVS icon
2
Bioventus
BVS
$1.17B
$119M 34.37%
13,021,324
– –
EYPT icon
3
EyePoint Inc
EYPT
$1.17B
$6.34M 1.83%
1,169,857
– –
TELA icon
4
TELA Bio
TELA
$32.3M
$5.02M 1.45%
4,110,709
– –
MNOV icon
5
MediciNova
MNOV
$65.5M
$1.61M 0.47%
1,105,941
– –
VERO
6
DELISTED
Venus Concept
VERO
$276K 0.08%
99,021
+4
+0% +$14
RVNC
7
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-457,085
Closed -$1.39M

Similar funds

TSM
Two Star Manager Miami Beach, Florida $254M AUM 3.61% 1-Year Est. Return
IGM
Incline Global Management New York $255M AUM 7.23% 1-Year Est. Return
WWM
Westwood Wealth Management Los Angeles, California $255M AUM 54.97% 1-Year Est. Return
MWM
MorganRosel Wealth Management Highlands Ranch, Colorado $254M AUM 18.87% 1-Year Est. Return
LRIC
Long Road Investment Counsel Kalamazoo, Michigan $255M AUM 12.85% 1-Year Est. Return
2
2Xideas Kusnacht, Switzerland $255M AUM 0.46% 1-Year Est. Return
ACM
Avos Capital Management Seattle, Washington $253M AUM 13.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Essex Woodlands Management's Q1 2025 Portfolio in Review

As of Q1 2025, Essex Woodlands Management held 7 positions worth $347M, down 20% from $433M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Essex Woodlands Management's Q1 2025 filing shows 1 increased and 1 closed positions. The largest sale was Revance Therapeutics, Inc., an estimated $1.39M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Essex Woodlands Management added most to Venus Concept in Q1 2025, an estimated $14 increase.
  • Essex Woodlands Management fully exited Revance Therapeutics, Inc. in Q1 2025, selling an estimated $1.39M.
  • Essex Woodlands Management's ten largest holdings make up 100% of its $347M portfolio in Q1 2025.
  • Essex Woodlands Management opened 0 new positions and closed 1 in Q1 2025.
  • Essex Woodlands Management's portfolio value fell 20% quarter-over-quarter to $347M.

Based on Essex Woodlands Management's 13F filing for Q1 2025, filed 13 May 2025.